Ningbo Menovo Pharmaceutical Balance Sheet Health
Financial Health criteria checks 3/6
Ningbo Menovo Pharmaceutical has a total shareholder equity of CN¥2.2B and total debt of CN¥1.3B, which brings its debt-to-equity ratio to 57.5%. Its total assets and total liabilities are CN¥4.3B and CN¥2.1B respectively. Ningbo Menovo Pharmaceutical's EBIT is CN¥26.1M making its interest coverage ratio 0.8. It has cash and short-term investments of CN¥617.2M.
Key information
57.5%
Debt to equity ratio
CN¥1.27b
Debt
Interest coverage ratio | 0.8x |
Cash | CN¥617.19m |
Equity | CN¥2.20b |
Total liabilities | CN¥2.14b |
Total assets | CN¥4.34b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 603538's short term assets (CN¥1.7B) exceed its short term liabilities (CN¥1.3B).
Long Term Liabilities: 603538's short term assets (CN¥1.7B) exceed its long term liabilities (CN¥846.5M).
Debt to Equity History and Analysis
Debt Level: 603538's net debt to equity ratio (29.5%) is considered satisfactory.
Reducing Debt: 603538's debt to equity ratio has increased from 38.8% to 57.5% over the past 5 years.
Debt Coverage: 603538's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 603538's interest payments on its debt are not well covered by EBIT (0.8x coverage).